BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6328695)

  • 1. HLA-DR antigens and the antibody response against Epstein-Barr virus.
    Cohen JH; Vischer TL; Carquin J; Blanchard F; von Fliedner VE; Jeannet M
    Tissue Antigens; 1984 Mar; 23(3):156-62. PubMed ID: 6328695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
    Strautins K; Tschochner M; James I; Choo L; Dunn DS; Pedrini M; Kermode A; Carroll W; Nolan D
    Mult Scler; 2014 Mar; 20(3):286-94. PubMed ID: 23886832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased antibody reactivity to Epstein-Barr virus capsid antigen in type 1 (insulin-dependent) diabetes mellitus.
    Hyöty H; Räsänen L; Hiltunen M; Lehtinen M; Huupponen T; Leinikki P
    APMIS; 1991 Apr; 99(4):359-63. PubMed ID: 1645169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
    Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
    J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-B8,DR3 phenotype and the antibody response against Epstein-Barr virus.
    Caruso C; Candore G; Colucci AT; Cigna D; Sammartano F; Ammatuna P
    Immunol Invest; 1993 Feb; 22(1):41-51. PubMed ID: 8382661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
    J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of immune complexes in rheumatoid arthritis for Epstein-Barr virus antigens reveals cross-reactivity of viral capsid antigen and human IgG.
    Inman RD; Chiu B; Hamilton NC
    J Immunol; 1987 Jan; 138(2):407-12. PubMed ID: 3025298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
    Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
    Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Performance of the VIDAS automated immunoassay for the determination of Epstein-Barr virus serological status].
    De Ory F; Guisasola ME; Sanz JC; García-Bermejo I
    Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):618-20. PubMed ID: 22854635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.
    Kvistad S; Myhr KM; Holmøy T; Bakke S; Beiske AG; Bjerve KS; Hovdal H; Løken-Amsrud KI; Lilleås F; Midgard R; Njølstad G; Pedersen T; Benth JŠ; Wergeland S; Torkildsen O
    Mult Scler; 2014 Dec; 20(14):1833-40. PubMed ID: 24842958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
    J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis and Epstein-Barr virus.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the presence of antibodies to the Epstein-Barr virus nuclear antigen type 2 and antibodies to the rheumatoid arthritis nuclear antigen in patients with rheumatoid arthritis.
    Sculley TB; Pope JH; Hazelton RA
    Arthritis Rheum; 1986 Aug; 29(8):964-70. PubMed ID: 3017369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to Epstein-Barr virus-specific antigens in patients with hairy-cell leukemia.
    Sakamoto K; Aiba M; Katayama I; Sullivan JL; Humphreys RE; Purtilo DT
    Int J Cancer; 1981; 27(4):453-8. PubMed ID: 6268553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined linkage and association studies show that HLA class II variants control levels of antibodies against Epstein-Barr virus antigens.
    Pedergnana V; Syx L; Cobat A; Guergnon J; Brice P; Fermé C; Carde P; Hermine O; Le-Pendeven C; Amiel C; Taoufik Y; Alcaïs A; Theodorou I; Besson C; Abel L
    PLoS One; 2014; 9(7):e102501. PubMed ID: 25025336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibodies against capsid (VCA) and nuclear (EBNA) antigens of the Epstein-Barr virus in patients with rheumatoid arthritis].
    Dostál C; Vojtĕchovský K; Hána I; Zvárová J
    Cas Lek Cesk; 1987 Feb; 126(8):237-40. PubMed ID: 3028635
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis.
    Catalano MA; Carson DA; Slovin SF; Richman DD; Vaughan JH
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5825-8. PubMed ID: 230491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.